<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116196">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02155868</url>
  </required_header>
  <id_info>
    <org_study_id>NIRS-in-CS</org_study_id>
    <nct_id>NCT02155868</nct_id>
  </id_info>
  <brief_title>Role of Cerebral Oximetry in Reducing Postoperative Morbidity Following Cardiac Surgery</brief_title>
  <official_title>Cerebral Near-Infrared Spectroscopy Monitoring in High-Risk Cardiac Surgery Patients: A Prospective, Randomised, Single-Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <authority>Russia: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral oximetry employing near-infrared spectroscopy (NIRS) is a non-invasive modality
      used to estimate regional cerebral oxygen content saturation (rSO2). Near-infrared
      spectroscopy has increasingly been used in perioperative setting of heart surgery and many
      studies have outlined an increased incidence of postoperative morbidity in patients with
      significant perioperative reductions in rSO2. Although a relationship between rSO2
      reductions and adverse outcomes has been reported, there is not compelling evidence that
      interventions to correct rSO2 during cardiac surgery lead to improved clinical outcomes.

      Hypothesis of the study is that interventions to normalize intraoperatively decreased
      cerebral rSO2 would reduce the overall incidence of postoperative complications in cardiac
      surgery patients with left ventricle ejection fraction less than 35%.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incidence of postoperative complications</measure>
    <time_frame>Up to 30 day after randomisation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>This composite outcome includes: myocardial infarction, stroke, delirium, postoperative cognitive dysfunction, wound infection, mediastinitis, mechanical ventilation more than 24 h, arrhythmia, reoperation for bleeding, acute kidney injury, and acute kidney injury requiring dialysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of major organ morbidity and mortality</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>This outcome includes: stroke, acute kidney injury requiring dialysis, mechanical ventilation more than 48 h, mediastinitis, reoperation, and death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intensive care unit stay</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative hospital stay</measure>
    <time_frame>Up to 30 day after randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death from all causes at 30 days</measure>
    <time_frame>Up to 30 day after randomisation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of desaturation episodes</measure>
    <time_frame>Intra operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Desaturation is defined as level of rSO2 less than 60%.</description>
  </other_outcome>
  <other_outcome>
    <measure>Severity of desaturation episodes</measure>
    <time_frame>Intra operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Severity is defined as the product of length of time and depth of rSO2 less than 60%</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C.
Predefined protocol of interventions for correcting rSO2 desaturation (&lt; 60%) during cardiac surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Only cerebral NIRS monitoring by means of FORE-SIGHT Universal Cerebral Oximeter MC-2030C.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Correction rSO2 desaturation during cardiac surgery.</intervention_name>
    <description>Predefined protocol of interventions for correcting rSO2 desaturation (&lt; 60%) during cardiac surgery.
In case of rSO2 decrease less than 60% correct:
head position; position of aortic,venous cannulae and central venous catheters; partial pressure of carbon dioxide in arterial blood  &lt; 35 mmHg; mean arterial pressure &lt; 60 mmHg; central venous pressure &gt; 10 mmHg; cardiac index &lt; 2.0 l/min/m2; mixed venous oxygen saturation &lt; 60%; hemoglobin &lt; 65 g/L during cardiopulmonary bypass or hemoglobin &lt; 90 g/L after cardiopulmonary bypass; decrease cerebral O2 consumption.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with left ventricle ejection fraction &lt; 35% scheduled for cardiac surgery

        Exclusion Criteria:

          -  refusal of consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir V Lomivorotov, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evgeny V Fominskiy, MD, PhD</last_name>
    <phone>+79139538754</phone>
    <email>evfominskiy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Academician EN Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <state>Novosibirsk Territory</state>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgeny V Fominskiy, MD, PhD</last_name>
      <phone>79139538754</phone>
      <email>evfominskiy@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Petr P Perovskiy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <reference>
    <citation>Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007 Jan;104(1):51-8.</citation>
    <PMID>17179242</PMID>
  </reference>
  <reference>
    <citation>Yao FS, Tseng CC, Ho CY, Levin SK, Illner P. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2004 Oct;18(5):552-8.</citation>
    <PMID>15578464</PMID>
  </reference>
  <reference>
    <citation>Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM 3rd, Rodriguez AL, Magovern CJ, Zaubler T, Freundlich K, Parr GV. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5.</citation>
    <PMID>19101265</PMID>
  </reference>
  <reference>
    <citation>Fischer GW, Lin HM, Krol M, Galati MF, Di Luozzo G, Griepp RB, Reich DL. Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery. J Thorac Cardiovasc Surg. 2011 Mar;141(3):815-21. doi: 10.1016/j.jtcvs.2010.05.017. Epub 2010 Jun 25.</citation>
    <PMID>20579669</PMID>
  </reference>
  <reference>
    <citation>Heringlake M, Garbers C, Käbler JH, Anderson I, Heinze H, Schön J, Berger KU, Dibbelt L, Sievers HH, Hanke T. Preoperative cerebral oxygen saturation and clinical outcomes in cardiac surgery. Anesthesiology. 2011 Jan;114(1):58-69. doi: 10.1097/ALN.0b013e3181fef34e. PubMed</citation>
    <PMID>21178669</PMID>
  </reference>
  <reference>
    <citation>Denault A, Deschamps A, Murkin JM. A proposed algorithm for the intraoperative use of cerebral near-infrared spectroscopy. Semin Cardiothorac Vasc Anesth. 2007 Dec;11(4):274-81.</citation>
    <PMID>18270192</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 4, 2014</lastchanged_date>
  <firstreceived_date>May 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meshalkin Research Institute of Pathology of Circulation</investigator_affiliation>
    <investigator_full_name>Evgeny Fominskiy, MD</investigator_full_name>
    <investigator_title>Mr</investigator_title>
  </responsible_party>
  <keyword>Cerebral near-infrared spectroscopy monitoring</keyword>
  <keyword>Postoperative complications</keyword>
  <keyword>Cardiac surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
